These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8147938)

  • 1. Reduction of mortality and lymphadenopathy in MRL-lpr/lpr mice treated with nonmitogenic anti-CD3 monoclonal antibody.
    Henrickson M; Giannini EH; Hirsch R
    Arthritis Rheum; 1994 Apr; 37(4):587-94. PubMed ID: 8147938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
    Jabs DA; Kuppers RC; Saboori AM; Burek CL; Enger C; Lee B; Prendergast RA
    Cell Immunol; 1994 Mar; 154(1):66-76. PubMed ID: 7907009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Prendergast RA
    Curr Eye Res; 1997 Sep; 16(9):909-16. PubMed ID: 9288452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burek CL; Hu Q; Kuppers RC; Lee B; Prendergast RA
    Cell Immunol; 1992 May; 141(2):496-507. PubMed ID: 1576659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
    Sawchuk SS; Gates R; Hirsch R
    Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice.
    Fossati L; Merino R; Iwamoto M; Lemoine R; Izui S
    Eur J Immunol; 1994 Jul; 24(7):1717-20. PubMed ID: 8026533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
    Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
    Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
    Davignon JL; Cohen PL; Eisenberg RA
    J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegaly in MRL/lpr mice.
    Takiguchi M; Murakami M; Nakagawa I; Rashid MM; Tosa N; Chikuma S; Hashimoto A; Uede T
    J Vet Med Sci; 2000 Jan; 62(1):29-36. PubMed ID: 10676886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
    Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
    J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-V beta 8 antibodies.
    de Alborán IM; Gonzalo JA; Kroemer G; Leonardo E; Marcos MA; Martínez C
    Eur J Immunol; 1992 Aug; 22(8):2153-8. PubMed ID: 1386316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
    Asensi V; Kimeno K; Kawamura I; Sakumoto M; Nomoto K
    Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal analysis of peripheral T cell precursors in lpr mice.
    Croghan TW; Rapaport R; Frelinger JS; Eisenberg RA; Cohen PL
    Autoimmunity; 1992; 12(4):295-302. PubMed ID: 1327247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.